U.S. pharma tariffs spare India’s generic drugmakers — but leave investors jittery by CNBC Markets | September 26, 2025 8:15 pm | US Markets Investors of Indian pharmaceutical companies are worried about the prospect of further escalation amid U.S. trade tensions.
